Revvity (NYSE:RVTY) Insider Tajinder Vohra Sells 7,330 Shares of Stock

by · The Cerbat Gem

Revvity Inc. (NYSE:RVTY – Get Free Report) insider Tajinder Vohra sold 7,330 shares of Revvity stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares of the company’s stock, valued at approximately $934,738.80. This represents a 52.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Revvity Trading Down 2.1%

NYSE:RVTY traded down $3.13 during mid-day trading on Friday, reaching $143.60. The company’s stock had a trading volume of 3,321,311 shares, compared to its average volume of 1,455,382. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. The stock has a market cap of $16.02 billion, a P/E ratio of 68.38, a P/E/G ratio of 2.65 and a beta of 1.09. The company’s fifty day simple moving average is $120.00 and its two-hundred day simple moving average is $104.45. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $149.52.

Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. During the same period in the prior year, the firm posted $1.18 EPS. The company’s revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities analysts predict that Revvity Inc. will post 5.36 EPS for the current year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.33%.

Institutional Investors Weigh In On Revvity

Large investors have recently modified their holdings of the stock. New Mexico Educational Retirement Board boosted its stake in Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock worth $524,000 after purchasing an additional 100 shares in the last quarter. Allworth Financial LP increased its stake in shares of Revvity by 8.9% in the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock valued at $123,000 after buying an additional 104 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Revvity by 5.4% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,074 shares of the company’s stock valued at $231,000 after buying an additional 106 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company’s stock worth $66,000 after buying an additional 109 shares in the last quarter. Finally, Angeles Wealth Management LLC lifted its position in Revvity by 2.0% during the 2nd quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company’s stock worth $646,000 after buying an additional 112 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. UBS Group assumed coverage on Revvity in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $140.00 target price on the stock. Weiss Ratings raised Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. KeyCorp boosted their target price on Revvity from $125.00 to $165.00 and gave the stock an “overweight” rating in a report on Friday, September 4th. Evercore restated an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. Finally, Sanford C. Bernstein began coverage on shares of Revvity in a research report on Friday, June 26th. They set a “market perform” rating and a $115.00 price target on the stock. Four analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat.com, Revvity has a consensus rating of “Hold” and a consensus target price of $116.57.

View Our Latest Report on RVTY

Revvity Company Profile

(Get Free Report)

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer’s Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.

Featured Articles